Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery

NCT00327379 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Blood Loss, Surgical
Postoperative Hemorrhage

Interventions

DRUG: Trasylol (Aprotinin, BAYA0128)
DRUG: Placebo

Sponsor

Bayer